BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer

Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...

January 24, 2022 | News

Kontrol Technologies Expands BioCloud Technology into Japan

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart buildings and cit...

January 17, 2022 | News

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health...

January 11, 2022 | News

PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery platform, today announced it has en...

January 05, 2022 | News

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...

December 29, 2021 | News

Linepharma International Files for Manufacturing, Marketing Approval of the Abortion Pill in Japan

The medication is recognized as the international gold standard for first trimester medical abortioni and is on the World Health Organization (WH...

December 23, 2021 | News

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®. The brand nam...

December 20, 2021 | News

Scientists from A*STAR GIS awarded CZI Ancestry Network Grant to investigate immune diversity in Singapore and Asia

A team of researchers, led by the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), was awarded the p...

December 20, 2021 | News

BostonGene and NEC Announce Global Partnership

BostonGene's innovative computational platform performs AI-based molecular and immune profiling to discover correlations between tumor genomics, a patient'...

December 15, 2021 | News

GenScript, BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

BC-PIV, an innovative non-transmissible viral vector co-developed by BioComo and Mie University, is derived from the recombinant human parainfluenza virus ...

December 03, 2021 | News

Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling

Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed the Single Cellome™ System SS2000, a single-cell analysis solution th...

December 02, 2021 | News

Japan to witness rapid serum blood collection tube technology

RAPClot™ serum tubes (evacuated blood collection tubes) produce high quality serum in less than five minutes, reducing the turnaround time from ...

November 30, 2021 | News

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" serv...

November 25, 2021 | News

Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K.

Healios noted that following its third quarter 2021 announcement of topline data from its ONE-BRIDGE clinical trial evaluating the safety and efficacy of M...

November 15, 2021 | News

Stay Connected